89 Why do almost half of our patients not complete 12 months of maintenance durvalumab after successful radical chemoradiotherapy?

{"title":"89 Why do almost half of our patients not complete 12 months of maintenance durvalumab after successful radical chemoradiotherapy?","authors":"Zaman Kawish khan , Roberts Dafydd Prys , Edwards Bleddyn , Brewster Alison , Vigneswaran Vallipuram , Lester Jason Farncis","doi":"10.1016/j.lungcan.2025.108199","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"200 ","pages":"Article 108199"},"PeriodicalIF":4.5000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500225001722","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}